JG
Highly rated in
46
conditions
Highly rated in
46
conditions
Check Dr. Jason R. Gotlib's experience treating your condition:
About Dr. Jason R. Gotlib

Jason Gotlib is a Hematologist and a Hematologist Oncology expert in Palo Alto, California. Gotlib has been practicing medicine for over 28 years and is highly rated in 46 conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Myelofibrosis, Myeloproliferative Neoplasms (MPN), Bone Marrow Transplant, and Bone Marrow Aspiration. He is licensed to treat patients in California. Gotlib is currently accepting new patients.

His clinical research consists of co-authoring 237 peer reviewed articles and participating in 21 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Jason R. Gotlib it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Jason R. Gotlib accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
875 Blake Wilbur Dr, Palo Alto, CA 94304
Background & Education
Graduate Institution
Stanford University School Of Medicine, 1995
Specialties
Hematology
Hematology Oncology
Licenses
Internal Medicine in CA
Hospital Affiliations
Stanford Hospital
Stanford Health Care - ValleyCare Medical Center
Community Hospital Of The Monterey Peninsula
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


18 Clinical Trials

Phase 2 Study of Ruxolitinib in Idiopathic Hypereosinophilic Syndrome and Primary Eosinophilic Disorders
A Phase I Dose Escalation Study of Ibrutinib With Idarubicin/Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia
Integrated Whole-Genome Analysis of Hematologic Disorders Using High-Throughput Sequencing and Array Technologies
A Phase 2 Study of Ibrutinib in Advanced Systemic Mastocytosis
A Phase 1 Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies
A Pilot Study of Lenalidomide in Adult Diamond-Blackfan Anemia Patients With Red Blood Cell Transfusion-Dependent Anemia
Prospective Evaluation of Ruxolitinib Efficacy for CNL/aCML Patients With Mutation of CSF3R
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
View 16 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors